文献
J-GLOBAL ID:200902174205453326
整理番号:96A0672065
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.
著者 (9件):
ROTHENBERG M L
(Cancer Therapy and Res. Center, TX, USA)
,
MOORE M J
(Princess Margaret Hospital, Toronto, CAN)
,
CRIPPS M C
(Ottawa Regional Cancer Center, Ontario, CAN)
,
ANDERSEN J S
(Lilly Res. Lab., IN, USA)
,
PORTENOY R K
(Memorial Sloan-Kettering Cancer Center, NY, USA)
,
BURRIS H A III
(Cancer Therapy and Res. Center, TX, USA)
,
GREEN M R
(Univ. California, CA, USA)
,
BROWN T D
(Duke Univ. Medical Center, NC, USA)
,
VON HOFF D D
(Cancer Therapy and Res. Center, TX, USA)
資料名:
Annals of Oncology
(Annals of Oncology)
巻:
7
号:
4
ページ:
347-353
発行年:
1996年04月
JST資料番号:
W0107A
ISSN:
0923-7534
CODEN:
ANONE2
資料種別:
逐次刊行物 (A)
発行国:
イギリス (GBR)
言語:
英語 (EN)